» Articles » PMID: 24052241

Improved Short Tau Inversion Recovery (iSTIR) for Increased Tumor Conspicuity in the Abdomen

Overview
Journal MAGMA
Publisher Springer
Date 2013 Sep 21
PMID 24052241
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Object: To develop an improved short tau inversion recovery (iSTIR) technique with simultaneous suppression of fat, blood vessels and fluid to increase tumor conspicuity in the abdomen for cancer screening.

Materials And Methods: An adiabatic spectrally selective inversion pulse was used for fat suppression to overcome the reduced signal to noise ratio associated with chemically non-selective inversion pulse of STIR. A motion-sensitizing driven equilibrium was used for blood vessel suppression and a dual-echo single-shot fast spin echo acquisition was used for fluid suppression. The technique was optimized on four normal subjects and later tested on five patients referred for metastatic tumor evaluation.

Results: A velocity encoding of 2 cm/s achieved effective blood suppression even in small vessels. Subtraction of two images (one with 60 ms and the other with 280 ms echo time) acquired in the same echo train achieved excellent fluid suppression (>70% reduction). Simultaneous suppression of fat, blood vessels and fluid improved the tumor conspicuity compared to corresponding fat-suppressed (STIR) image.

Conclusion: This technique generated two complementary images from a single scan: one that is equivalent to a STIR image and the other that qualitatively resembles a diffusion-weighted image and may have potential for magnetic resonance imaging cancer screening.

Citing Articles

New options for increasing the sensitivity, specificity and scope of synergistic contrast magnetic resonance imaging (scMRI) using Multiplied, Added, Subtracted and/or FiTted (MASTIR) pulse sequences.

Ma Y, Shao H, Fan S, Lu X, Du J, Young I Quant Imaging Med Surg. 2020; 10(10):2030-2065.

PMID: 33014733 PMC: 7495319. DOI: 10.21037/qims-20-795.


Use of Multiplied, Added, Subtracted and/or FiTted Inversion Recovery (MASTIR) pulse sequences.

Ma Y, Fan S, Shao H, Du J, Szeverenyi N, Young I Quant Imaging Med Surg. 2020; 10(6):1334-1369.

PMID: 32550142 PMC: 7276363. DOI: 10.21037/qims-20-568.


Whole-body MRI for metastatic cancer detection using T -weighted imaging with fat and fluid suppression.

Wang X, Pirasteh A, Brugarolas J, Rofsky N, Lenkinski R, Pedrosa I Magn Reson Med. 2018; 80(4):1402-1415.

PMID: 29446127 PMC: 6092263. DOI: 10.1002/mrm.27117.

References
1.
Koktzoglou I, Kirpalani A, Carroll T, Li D, Carr J . Dark-blood MRI of the thoracic aorta with 3D diffusion-prepared steady-state free precession: initial clinical evaluation. AJR Am J Roentgenol. 2007; 189(4):966-72. DOI: 10.2214/AJR.07.2428. View

2.
Wang J, Yarnykh V, Hatsukami T, Chu B, Balu N, Yuan C . Improved suppression of plaque-mimicking artifacts in black-blood carotid atherosclerosis imaging using a multislice motion-sensitized driven-equilibrium (MSDE) turbo spin-echo (TSE) sequence. Magn Reson Med. 2007; 58(5):973-81. DOI: 10.1002/mrm.21385. View

3.
Fazekas F, Barkhof F, Filippi M, Grossman R, Li D, McDonald W . The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology. 1999; 53(3):448-56. DOI: 10.1212/wnl.53.3.448. View

4.
Ono K, Ochiai R, Yoshida T, Kitagawa M, Omagari J, Kobayashi H . Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases. J Magn Reson Imaging. 2009; 29(2):336-40. DOI: 10.1002/jmri.21638. View

5.
Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller S, Beyer T . Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol. 2004; 22(21):4357-68. DOI: 10.1200/JCO.2004.08.120. View